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The transition from childhood to adolescence and early adulthood
is particularly important for the study of attention-deficit hyper-
activity disorder (ADHD), a childhood-onset neurodevelopmental
disorder that has long-term impact throughout the lifespan.1
Despite high rates of persistence of ADHD, around a third of
individuals no longer meet diagnostic criteria for ADHD during
young adulthood and appear free of clinical impairment.2,3 Yet,
there is a scarcity of research investigating the cognitive and
neurobiological processes relating to the developmental pathways
towards persistence or remission of ADHD.4 Identifying the
mechanisms of ADHD remission may inform development of
novel treatment strategies that improve the outcomes in ADHD.
Although longitudinal cognitive data on ADHD are limited
and inconclusive,5 cross-sectional data on cognitive impairments
and their aetiology in ADHD point to an aetiological separation
of cognitive impairments in ADHD. Genetic model fitting analyses
on two independent samples of ADHD and control sibling pairs
consistently identified two familial cognitive impairment factors
in ADHD: the first factor capturing increased reaction time
variability (RTV)6 and intra-individual variability of responses,7
and the second executive function impairments, including
response inhibition6 and working memory.7 Recent twin analyses
further confirm the aetiological separation between RTV and
inhibition.8 In addition to the two (at least partially) separable
familial cognitive impairment factors in ADHD, further largely
separable aetiological influences underlie the association between
ADHD and lower IQ.9–11 Neurophysiological studies reveal
atypical patterns of electroencephalogram (EEG) oscillatory
activity12 and attenuated event-related potential (ERP) activity,
including measures of inhibition (nogo-P3 amplitudes), preparation
(contingent negative variations, CNVs) and attention orientation
(cue P3 amplitudes) in both children and adults with ADHD,13–15
but data on EEG/ERP markers of persistence and remittance are as
yet lacking.
The present study follows up individuals with childhood
ADHD, who during childhood assessments demonstrated
impairment in cognitive measures of RTV, Go/No-Go (GNG) task
commission error (CE) and omission error (OE),6,8,16,17 IQ10 and
digit spans,18 and had a higher mean and variability of objectively
measured actigraph movement intensity and count.19 We now aim
to identify markers of underlying behavioural, cognitive and
neurophysiological processes that relate to (a) an enduring deficit
that continues to be impaired in those with childhood ADHD,
irrespective of whether their ADHD symptoms have improved;
and (b) remission of ADHD symptoms and associated impair-
ments during the transition from childhood to adolescence/early
adulthood. In addition to cognitive performance and actigraph
measures, we focus on EEG frequency bands (delta, theta, alpha
and beta) and ERP measures from the cued continuous perform-
ance task (CPT-OX) (CNV, cue-P3 and nogo-P3 amplitudes),
which have previously demonstrated sensitivity to ADHD.13,15
As well as defining ADHD outcome using a categorical diagnosis
of persistence, we also examine ADHD symptoms and related
impairments at follow-up as continuous traits.
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Background
Attention-deficit hyperactivity disorder (ADHD) persists in
around two-thirds of individuals in adolescence and early
adulthood.
Aims
To examine the cognitive and neurophysiological processes
underlying the persistence or remission of ADHD.
Method
Follow-up data were obtained from 110 young people
with childhood ADHD and 169 controls on cognitive,
electroencephalogram frequency, event-related potential
(ERP) and actigraph movement measures after 6 years.
Results
ADHD persisters differed from remitters on preparation-
vigilance measures (contingent negative variation, delta
activity, reaction time variability and omission errors), IQ and
actigraph count, but not on executive control measures of
inhibition or working memory (nogo-P3 amplitudes,
commission errors and digit span backwards).
Conclusions
Preparation-vigilance measures were markers of remission,
improving concurrently with ADHD symptoms, whereas
executive control measures were not sensitive to ADHD
persistence/remission. For IQ, the present and previous
results combined suggest a role in moderating ADHD
outcome. These findings fit with previously identified
aetiological separation of the cognitive impairments in ADHD.
The strongest candidates for the development of non-
pharmacological interventions involving cognitive training and
neurofeedback are the preparation-vigilance processes that
were markers of ADHD remission.
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Method
Participants
The sample consists of 279 participants, who were followed up on
average 5.8 years (s.d. = 1.1) after initial assessments: 110 had a
diagnosis of DSM-IV combined type ADHD in childhood (10
sibling pairs and 90 singletons) and 169 were control participants
(76 sibling pairs and 17 singletons; online Table DS1).
Participants with ADHD were initially recruited from
specialised ADHD clinics in the UK.6,20 Research diagnosis of
DSM-IV combined type ADHD was established using the Parental
Account of Children’s Symptoms (PACS), a semi-structured,
standardised, investigator interview with high interrater
reliability.20 The control group was initially recruited from schools
in the UK, aiming for an age and gender match with the clinical
sample. All participants were aged between 6 and 17 at the initial
assessment. The same exclusion criteria were applied for all
participants at the baseline childhood assessment: IQ570, autism,
epilepsy, general intellectual difficulties, brain disorders and any
genetic or medical disorder associated with externalising
behaviours that might mimic ADHD. Parents of all participants
gave informed consent following procedures approved by the
London-Surrey Borders Research Ethics Committee (09/H0806/58).
At follow-up, six control participants met DSM-IV ADHD
criteria based on the parent-rated Barkley Informant Rating
Scale21 and six participants with ADHD had missing parent
ratings of clinical impairments; these participants were therefore
excluded from the analysis. Two participants with childhood
ADHD, who did not meet ADHD symptom criteria but met
clinical levels of impairment at follow-up, had different cognitive
profiles compared with the other individuals from the remitted
group, and were also excluded to minimise heterogeneity in the
sample.
Among those with childhood ADHD diagnosis, 87 (79%)
continued to meet clinical (DSM-IV) levels of ADHD symptoms
and impairment and were classified as ADHD persisters, 23
(21%) were below the clinical cut-off and were classified as ADHD
remitters. Of the ‘remitted’ individuals, 14 displayed five or more
items on either the inattention or hyperactivity-impulsivity
symptom domains, but did not show functional impairment (less
than two domains). At follow-up, ADHD persisters, remitters and
controls did not differ in age, but there were significantly more
males in the remitted group than in the other two groups (Table
1). The follow-up duration for the persistent group ranged from
4.41 to 9.08 years (mean= 6.56; s.d. = 0.80), with 75% of
participants assessed between 5 and 7 years. The remittent group
were assessed between 4.50 and 8.54 years (mean= 6.39;
s.d. = 0.94), with 70% of participants followed up within 5–7
years. The follow-up duration was not significantly different
between the two groups (z=0.80, P=0.43).
Almost half (47%) of the participants were under medication
treatment for ADHD at the time of the follow-up assessment.
Those who were on medication had significantly higher ADHD
symptoms (F= 11.34, P50.01) and exhibited more functional
impairment (F=5.22, P50.01) than those who were not on
medication at follow-up. However, the proportion of participants
on medication at follow-up did not differ between the persistent
and remittent groups (w= 1.95, P= 0.16).
Procedure
Participants were re-contacted by telephone and scheduled for a
follow-up clinical interview and a cognitive-EEG assessment with
simultaneous actigraph assessment at the same research centre
where the initial assessment took place. For those prescribed
stimulants (n= 52), a 48-hour ADHD medication-free period
was required prior to cognitive-EEG assessments. The total
length of the test session, including breaks, was approximately
4 h. Participants received verbal and written information about
the aims and procedures of the study and gave written informed
consent.
Measures
The Diagnostic Interview for ADHD in adults (DIVA)21
The DIVA is a semi-structured interview designed to evaluate the
DSM-IV criteria for both adult and childhood ADHD symptoms
and impairment. The DIVA was conducted by trained researchers
with parents of the ADHD proband.22
The Barkley Functional Impairment Scale (BFIS)22
This 10-item scale is used to assess the levels of functional impair-
ments commonly associated with ADHD symptoms in five areas
of everyday life: family/relationship; work/education; social inter-
action; leisure activities; and management of daily responsibilities.
Each item ranged from 0 (never or rarely) to 3 (very often).
Participants were classified as ‘affected’ at follow-up if
they scored a ‘yes’ on56 items in either the inattention or hyper-
activity-impulsivity domains on the DIVA, and they scored52 on
two or more areas of impairments on the BFIS.
IQ and digit span
The vocabulary and block design subtests of the Wechsler
Abbreviated Scale of Intelligence (WASI)23 were administered to
all participants to derive an estimate of IQ. The digit span subtest
from the Weschler Intelligence Scale for Children (WISC-III)24 or
the Weschler Adult Intelligence Scale (WAIS-III)25 was administered
to participants aged below 16 and aged 16 or above respectively, to
obtain digit span forward (DSF) and backward (DSB). The forward
test requires the participant to verbally repeat a sequence of digits
in the straightforward order, and is a measure of short-term verbal
memory.
Actigraph measures of activity level
The actigraph readings used in the current analyses were taken
during the clinical interviews and cognitive-EEG assessments.
The total length of the testing session was approximately 3 h,
excluding a 30-minute unstructured break given approximately
halfway through the session when actigraph measurements were
not analysed. Two actigraph measures, which we previously
showed to reliably distinguish between ADHD probands and
controls (receiver operating characteristic-area under the curve=
0.61–0.79),19 were obtained from the dominant ankle of each
participant: the mean intensity of movements (mean intensity),
and the mean number of movements (mean count).
The Fast Task
The baseline condition consists of 72 trials, which followed a
standard warned four-choice reaction time task.16 Four empty
circles (warning signals, arranged horizontally) first appeared for
8 s, after which one of them (the target) was coloured in. Parti-
cipants were asked to press the response key that directly
corresponded to the position of the target stimulus. Following a
response, the stimuli disappeared from the screen and a fixed
inter-trial interval of 2.5 s followed. Speed and accuracy were
emphasised equally. If the participant did not respond within
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10 s, the trial terminated. A comparison condition with a fast
event rate (1 s) and incentives followed the baseline condition.16
Cognitive performance measure of RTV from the baseline condition
was included in this analysis, as this condition is more sensitive to
ADHD.26
The cued flanker CPT-OX
This CPT includes rare cued Go and No-Go conditions embedded
in a vigilance task with frequent distractors to assess both
attentional and inhibitory processes.27,28 The test consists of 400
letters presented for 150ms with an SOA (stimulus onset
asynchrony) of 1.65 s in a pseudorandomised order at the centre
of a computer monitor. The viewing distance to the monitor
measured 120 cm at a vertical visual angle of approximately
0.58. The cue letter O occurred with 20% probability (80 cue
stimuli), signalled a GNG task, and induced response preparation.
Participants pressed a mouse button with the index finger of their
dominant hand as fast as possible every time the cue was followed
directly by the letter X (O-X) target sequence (10% probability, 40
Go stimuli) but had to withhold responses to O-not-X sequences
(No-Go trials, also 10%, 40 No-Go stimuli). Cognitive performance
measures of RTV, CE, OE; EEG measures of delta, theta, alpha and
beta power; and ERP amplitude measures of CNV, cue-P3 and
nogo-P3 were obtained from this task.
EEG recording and processing
The EEG was recorded from 62 channels DC-coupled recording
system (extended 10–20 montage), with a 500Hz sampling rate,
impedances kept under 10 kO, and FCz as the reference electrode.
The electro-oculograms (EOGs) were recorded from electrodes
above and below the left eye and at the outer canthi.
The EEG data were analysed using Brain Vision Analyser (2.0)
(Brain Products, Germany). After down-sampling the data to
256Hz, the EEG data were re-referenced to the average and
filtered offline with digitally band-pass (0.1–30Hz, 24 dB/oct)
Butterworth filters. Ocular artefacts were identified from the data
using Independent Component Analysis (ICA).29 The extracted
independent components were manually inspected and ocular
artefacts were removed by back-projection of all but those
components. Data with other artefacts exceeding +100mV in
any channel were rejected. No baseline subtraction was applied
in line with previous ERP analyses on this task.13–15 All averages
contained at least 20 sweeps.
ERP analyses
The CNVs were analysed as mean amplitudes between 1300 and
1650ms following cues over the central electrode (Cz). The cue-P3
had a parietal maximum and was defined as the most positive peak
between 250 and 600ms following cue trials at electrode Pz. The
nogo-P3 was defined as the most positive peak between 250 and
600ms following No-Go trials at electrode Cz.
EEG frequency analyses
We estimated the mean EEG power (mV2) in the delta (0.5–3Hz),
theta (4–7Hz), alpha (7–12Hz) and beta (12–30Hz) bands using
the Fast Fourier Transform (FFT). To reduce the number of
statistical comparisons, we analysed the frontal location only, which
has consistently been reported as sensitive to ADHD impairment,
by computing the mean activity of electrodes (F1–F8, Fz).
Statistical analyses
We ran regression models with dummy variables to identify which
measures showed an overall effect of group (ADHD persisters v.
ADHD remitters v. controls), with controls as the reference group.
On measures that indicated differences between ADHD persisters
and controls, post hoc t-tests were conducted to examine the
differences between ADHD persisters and remitters on these
measures. As all three groups were matched on age at follow-up,
this variable was not included as a covariate. We explored the
effect of gender by re-running all analyses with the females
(n=15) removed; the pattern of results remained the same.
Cohen’s d effect sizes are presented along with means, standard
deviations and test statistics for the group analyses (Table 1),
where 0.2 is considered a small effect, 0.5 a medium effect and
0.8 a large effect. Pearson correlations were also conducted on
these measures to examine their associations with DIVA ADHD
symptom scores, and clinical impairment within those who had
a childhood ADHD diagnosis, with age and gender included as
covariates.
All analyses were conducted first without controlling for IQ;
we then re-ran the analysis covarying for IQ to examine its
potential effects. All cognitive measures and EEG frequency
measures were skewed and log-transformed to normal in STATA
version 10 (StataCorp, College Station, Texas, USA). We also con-
trolled for genetic relatedness of the sibling pairs using the ‘robust
cluster’ command in STATA.30
Results
Means and standard deviations on all the measures in the ADHD-
persistent, ADHD-remittent and control groups are reported in
the data supplement (Table DS1).
Which measures show ADHD-control differences
at follow-up?
ADHD-persistent and control group differences were observed on
all measures (Table 1). For delta, theta, alpha and beta activity, as
well as DSF, the ADHD-persistent v. control group difference was
no longer significant, when IQ was included as a covariate (all
P40.05).
RTV (Fast Task), IQ, OE and actigraph mean count
discriminated between ADHD-persistent and controls with a large
effect size, whereas medium effect sizes were observed for
actigraph mean intensity, RTV (from CPT-OX), digit spans
(forward and backward), CE, nogo-P3 and CNV (Table 1). Other
ERP and EEG measures, including cue-P3, delta, theta, alpha and
beta activity had small effect sizes (Table 1). Controlling for IQ led
to some reduction in effect sizes for most variables (Table 1); effect
size was large now only for RTV from Fast Task.
Which processes are markers of recovery that
distinguish between ADHD persisters and remitters?
ADHD remitters were significantly different from ADHD
persisters, and not significantly different from controls, on
measures of IQ, RTV, OE, CNV, delta and theta activity, actigraph
intensity and count (Table 1, Fig. 1(a)). In addition, for cue-P3
amplitudes we observed a similar but non-significant pattern of
findings: ADHD remitters were not significantly different from
controls (Table 1 and Fig. 1(b)), and both the comparisons be-
tween the ADHD-persistent v. ADHD-remittent and between
ADHD-persistent v. controls were of medium effect sizes,
although the former was not significant (P= 0.18).
As ADHD persisters had a lower IQ than ADHD remitters
(Table 1), we re-ran the analyses while controlling for effects
of IQ for all variables. The group differences between ADHD
persisters and remitters remained significant for RTV (P= 0.03),
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OE, actigraph intensity and count (all P50.01), but controlling
for IQ diminished the group effects for CNV amplitude, delta
and theta power which were no longer significant (Table 1).
The effect sizes remained similar for alpha power and cue-P3
amplitude when controlling for IQ.
Which processes continue to be impaired
in those with childhood ADHD diagnosis,
irrespective of current ADHD status?
The full requirement for an enduring deficit would be a significant
ADHD-remittent v. control group difference but no ADHD-persister
v. ADHD-remittent group difference. Here, although ADHD
remitters were not significantly different from ADHD persisters
on several of the measures, none of the measures showed
significant differences between the ADHD remitters and controls
(Table 1). Therefore, none of the processes investigated in this
study fulfilled the strict criteria for enduring deficits, when using
categorical diagnoses.
However, several variables did not differ significantly between
ADHD persisters and remitters, and the effect size for the ADHD
remittent v. control comparison was comparable to the effect size
of the ADHD persistent-remittent comparison (around 0.30).
Such a pattern, where the ADHD remitters are in the middle, in
between the other two groups, was observed for DSB, CE and
nogo-P3 (Fig. 2). With IQ as a covariate, the pattern remained
unchanged for CE and nogo-P3 amplitudes, although the effect
size for the ADHD persistent-remittent comparison on DSB
reduced from 0.31 to 0.08 (Table 1).
Which processes are associated with ADHD
symptoms and clinical impairment at follow-up within
those who had a childhood ADHD diagnosis?
ADHD symptoms and impairment at follow-up correlated
significantly with IQ, RTV (from both tasks), OE, delta activity
and actigraph count, whereas actigraph intensity was associated
only with impairment (Table 2). No other significant associations
were observed.
When we re-ran the analysis with IQ as a covariate in addition
to gender and age, RTV from the CPT-OX was no longer
significantly associated with impairment, and OE and delta were
no longer associated with ADHD symptoms (online Table DS2).
All the other correlations remained significant. Of the variables
on which ADHD remitters were in-between ADHD persisters
and controls, the expected lack of association with ADHD symp-
toms was observed for No-Go P3 amplitudes, CE and DSB, with
correlations non-significant and low at 70.01 to 70.12.
Discussion
This follow-up study of 110 adolescents and young adults with
childhood combined type ADHD and 169 controls identified
three cognitive processes in relation to ADHD outcome. The first
process encompasses preparation-vigilance measures (OE, RTV,
CNV, delta and theta activity, and a trend for cue-P3 amplitude
and alpha activity), as well as objectively measured physical
activity (actigraph intensity and count), which are no longer
impaired in individuals whose ADHD symptoms improve and
represent markers of remission. As these processes are associated
with improvement in ADHD, they may also potentially mediate
ADHD outcome; further studies are required to investigate this
possibility. The second process involves executive control processes
of inhibition and working memory (commission errors (CE),
nogo-P3 and DSB), on which ADHD remitters lie intermediate
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Table 1 Group comparisons on age, gender, IQ, digit
span, cognitive performance, ERP, EEG and actigraph
measures
F (d.f.) P Cohen’s d’
Cohen’s d’
(IQ controlled)
Mean age (s.d.) 1.45
(2, 192)
0.15
Male, n (%) 7.65
(2, 192)
0.02
Cognitive measures
IQ 22.35
(2, 192)
50.01
70.99a**
70.58b*
70.41c
Digit span forward 7.40
(2, 192)
50.01
70.55a**
70.36b
70.19c
70.23a
70.14b
70.04c
Digit span backward 13.01
(2, 192)
50.01
70.70a**
70.31b
70.40c
70.34a*
70.08b
70.21c
RTV (CPT-OX) 10.86
(2, 192)
50.01
0.68a**
0.55b**
70.08c
0.48a**
0.44b*
70.09c
RTV (fast task) 31.57
(2, 190)
50.01
1.23a**
0.62b**
0.29c
0.83a**
0.44b*
0.19c
CE (CPT-OX) 10.28
(2, 191)
50.01
0.69a**
0.28b
0.24c
0.47a**
0.17b
0.19c
OE (CPT-OX) 18.88
(2, 191)
50.01
0.93a**
0.77b**
0.10c
0.63a**
0.59b**
0.04c
ERPs (CPT-OX)
CNV 6.52
(2, 190)
50.01
0.54a**
0.42b*
0.07c
0.45a**
0.39b
0.05c
Cue P3 3.68
(2, 190)
0.03
70.37a**
70.27b
70.02c
70.39a**
70.30b
70.05c
No-Go P3 8.09
(2, 188)
50.01
70.61a**
70.22b
70.27c
70.57a**
70.23b
70.27c
EEG frequency bands
(CPT-OX)
Delta 4.84
(2, 189)
50.01
0.44a**
0.45b*
70.11c
0.18a
0.35b
70.18c
Theta 3.89
(2, 189)
0.02
0.35a*
0.50b*
70.14c
0.12a
0.36b
70.20c
Alpha 3.28
(2, 189)
0.04
0.39a*
0.22b
0.14c
0.29a
0.17b
0.13c
Beta 2.36
(2, 189)
0.10
0.33a*
0.15b
0.08c
0.18a
0.13b
0.04c
Actigraph movement
Mean intensity 10.77
(2, 169)
50.01
0.71a**
0.60b**
0.04c
0.59a**
0.53b*
0.00c
Mean count 13.77
(2, 143)
50.01
0.87a**
0.80b**
0.01c
0.59a**
0.70b*
70.03c
ERP, event-related potential; EEG, electroencephalogram; CPT-OX, continuous
performance task; RTV, reaction time variability; CE, commission errors; OE, omission
errors; CNV, continuous negative variation.
a. ADHD persisters v. controls.
b. ADHD persisters v. ADHD remitters.
c. ADHD remitters v. controls.
Cohen’s effect sizes (d’) are presented without and with IQ included as a covariate.
Significant group differences are indicated in bold.
*P50.05, **P50.01.
Cognitive and EEG markers of ADHD persistence
between ADHD persisters and controls, though were not signifi-
cantly different from either group. These markers of executive
control were not associated with follow-up ADHD symptoms or
impairment.
IQ represents a third process, as a potential moderator of
ADHD outcome. We previously found childhood IQ to predict
future ADHD outcome in the present sample, whereas other
cognitive variables, such as RTVand CE, did not.31 In this analysis,
moderator variables reflect baseline characteristics that predict
change in ADHD symptoms over development. This is different
from mediating variables, which reflect mediating effects that
explain the change in ADHD symptoms such that change in a
mediator would predict change in ADHD. Our findings suggesting
that IQ is a moderator rather than a mediator of ADHD outcome
is also consistent with findings from longitudinal treatment
studies, which report positive associations between childhood
IQ in ADHD and treatment response.32,33 In the current analyses
we further demonstrate that ADHD remitters have a higher IQ than
ADHD persisters at follow-up. Aetiological influences on ADHD
and IQ have also been shown to largely separate from those on
the other cognitive impairments in ADHD.9–11 Overall, the
convergent findings emphasise the role of IQ in the developmental
course of ADHD, and demonstrate the potential risk of poor
outcome in children with concurrent ADHD symptoms and low
IQ. In the present analyses IQ differences between the groups
accounted also for some of the observed group differences on
verbal short-term memory (DSF) and EEG activity across the
frequency bands.
With regard to the first two processes, our results are largely
consistent with the previously observed separation of ADHD-
related impairments into executive function v. preparation-vigilance
processes.6,34,35 Although a distinction between potential top-down
cognitive control and bottom-up arousal regulation was also made
in a previous developmental ADHD model,36,37 the pattern
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Fig. 1 Waveform event-related potentials and topographical maps for the (a) contingent negative variation (CNV) at central electrode (Cz)
and (b) cue-P3 amplitudes at parietal electrode (Pz) in attention-deficit hyperactivity disorder (ADHD) persisters (dash), ADHD remitters (dot)
and controls (solid).
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observed in our data is not consistent with the model’s predictions
of how the impairments map onto persistence and remittance.
The present study adds to existing knowledge by drawing direct
comparisons between ADHD persisters and remitters, with an
inclusion of both cognitive and neurophysiological measures,
as well as a long follow-up period. Our data suggest that the
preparation-vigilance markers, rather than executive control
processes, are markers of remission in ADHD.
Previous observations of ADHD-sensitive improvement in
RTV but not in inhibitory deficits following incentives17,38,39 are
also consistent with our findings that, relative to executive control
processes such as inhibition, RTVand related measures may reflect
a more malleable process and show a stronger association with the
improvement of ADHD symptoms. An important direction for
future research will be to link the cognitive and EEG markers
of remission and persistence to the interdependent but partially
separate neural networks identified in functional magnetic resonance
imaging studies on ADHD, which include the frontal-parietal
network, the default-mode network and the ventral-attentional
network.40,41
Our further analyses on continuous measures of ADHD
outcome confirmed the association of IQ, RTV, OE, delta and
actigraph movement count with both ADHD symptoms and
impairment at follow-up, and the lack of such an association for
DSB, CE and nogo-P3 amplitudes. Exceptions to the pattern
expected based on group comparisons were obtained for theta
6
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Fig. 2 Waveform event-related potentials and topographical maps for nogo-P3 at central electrode (Cz), in attention-deficit hyperactivity
disorder (ADHD) persisters (dash), ADHD remitters (dot) and controls (solid).
Table 2 Pearson correlations (two-tailed) of IQ, digit span, cognitive performance, ERP, EEG and actigraph measures with
interview-based DIVA ADHD symptoms and clinical impairment within the ADHD group only (n = 110), without controlling for IQ
ADHD symptoms Impairment
r P r P
IQ 70.26 50.01 70.27 50.01
Digit span forward 70.07 0.50 70.11 0.24
Digit span backward 70.12 0.20 70.13 0.19
RTV (CPT-OX) 0.25 50.01 0.19 0.05
RTV (fast task) 0.26 0.01 0.26 50.01
Commission errors 70.01 0.99 0.17 0.08
Omission errors 0.19 0.05 0.27 50.01
CNV 0.03 0.80 0.12 0.24
Cue P3 70.10 0.36 70.12 0.23
No Go P3 70.07 0.48 70.04 0.72
Delta 0.21 0.04 0.27 0.01
Theta 0.08 0.43 0.07 0.46
Alpha 0.06 0.56 0.07 0.45
Beta 70.06 0.53 0.09 0.37
Movement intensity 0.20 0.07 0.23 0.03
Movement count 0.33 50.01 0.36 50.01
ERP, event-related potential; EEG, electroencephalogram; DIVA, Diagnostic Interview for ADHD in adults; ADHD, attention-deficit hyperactivity disorder; CPT-OX, continuous
performance task; RTV, reaction time variability; CNV, continuous negative variation.
Significant correlations are indicated in bold.
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activity and CNV. The findings for OE in relation to the underlying
process that it captures are less consistent than for other cognitive
performance variables: whereas the present data on OE merging
with RTV rather than CE is consistent with previous studies on
the arousal-attention model,35 in our two-factor familial model
OE merged with CE at the familial level (although at the level
of individual-specific environmental influences OE loaded both
onto the ‘RTV’ and ‘CE’ factors).6
A limitation of this study is that the sample covers only
adolescence and young adults, where some younger individuals
are still undergoing fundamental changes in brain development.
Although, importantly, our study groups were matched for age,
it would be informative to examine the hypotheses again in future
follow-up assessments when all participants have reached
adulthood and more ADHD participants may have remitted.
Overall, our findings and evidence from earlier research raise
the possibility that cognitive impairments in ADHD reflect (at
least) three processes: markers of recovery, potential moderators
of ADHD outcome and processes that are not significantly
associated with ADHD outcome in adolescence and early
adulthood. Although these possibilities await rigorous testing in
future studies, the pattern would fit with the previously identified
aetiological separation of the cognitive impairments in ADHD
into three main groups (response variability, lower IQ and
executive function impairments),6,7 and raises intriguing
questions on possible links to the neuroimaging networks
identified in ADHD.40,41 For both researchers and clinicians, these
findings highlight the importance of a developmental approach to
ADHD. Based on these data, the strongest candidates for the
development of non-pharmacological interventions involving
cognitive training and neurofeedback are the preparation-
vigilance processes that we identified as markers of ADHD
remission.
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Cheung et al. Cognitive and neurophysiological markers of ADHD persistence and 
remission. Br J Psychiatry 2015 (doi: 10.1192/bjp.bp.114.145185) 
 
Table DS1 Group means and standard deviations on age, gender, IQ, digit span, cognitive performance, ERP, EEG and actigraph measures  ADHD persisters (n = 87) ADHD  remitters  (n = 23) Controls  (n =169) Mean age (SD) 18.27 (3.03) 18.89 (3.06) 17.77 (2.19) 
Male n (%) 72 (83%) 23 (100%) 136 (77%) 
Cognitive measures   IQ 96.20 (15.33)  104.57 (13.63)  109.98 (12.42) Digit span forward 9.29 (2.01) 10.04 (2.18) 10.44 (2.14) Digit span backward 6.22 (2.38) 6.96 (2.46) 7.99 (2.64) RTV (CPT-OX) 110.47 (56.35) 79.52 (50.70) 78.87 (36.76) RTV (Fast Task)  182.32 (129.20) 122.98 (77.00) 102.10 (82.82) CE (CPT-OX) 2.12 (2.60) 1.43 (2.02) 0.87 (1.33) OE (CPT-OX)  2.76 (4.07) 0.79 (1.36) 0.59 (1.00) 
ERPs (CPT-OX)    CNV -2.90(2.02) -3.73 (1.75) -3.85 (1.85) Cue P3 5.46 (2.58) 6.31 (2.76) 6.38 (2.45) No-go P3 6.68 (4.60) 7.80 (4.12) 9.10 (3.90) 
EEG frequency bands (CPT-OX)   Delta 6.04(3.89) 4.45(2.26) 4.67(2.37) Theta 1.13(0.86) 0.79 (0.36) 0.90 (0.63) Alpha 0.91 (0.78) 0.71 (0.44) 0.67 (0.48) Beta 0.24 (0.19) 0.22 (0.17) 0.20 (0.14) 
Actigraph movement   Mean intensity 1.21 (0.74) 0.77 (0.47) 0.78 (0.55) Mean count 0.05 (0.04) 0.02 (0.01) 0.03 (0.06)  RTV, reaction time variability; CE, commission errors; OE, omission errors; CNV, continuous negative variation 
 
  
Table DS2 Pearson correlations (two-tailed) of digit span, cognitive performance, ERP, EEG and actigraph measures with interview-based ADHD symptoms and clinical impairment within the ADHD group only (n=110), controlling for IQ 
RTV, reaction time variability; CE, commission errors; OE, omission errors; CNV, continuous negative variation 
 ADHD symptoms Impairment  r p r p Digit span forward -0.00 0.97 -0.03 0.78 Digit span backward -0.01 0.92 -0.02 0.84 RTV (CPT-OX) 0.20 0.04 0.13 0.20 RTV (Fast Task) 0.22 0.03 0.21 0.03 Commission errors  -0.08 0.41 0.10 0.28 Omission errors 0.12 0.22 0.21 0.03 CNV -0.00 1.00 0.10 0.33 Cue P3 -0.08 0.43 -0.11 0.25 No Go P3 -0.12 0.22 -0.04 0.67 Delta  0.17 0.10 0.23 0.02 Theta  0.04 0.67 0.04 0.70 Alpha  -0.07 0.48 0.09 0.37 Beta  0.06 0.52 0.12 0.21 Movement intensity 0.18 0.10 0.21 0.05 Movement count 0.32 <0.01 0.35 <0.01 
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